BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 20801094)

  • 1. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
    Cupp EW; Sauerbrey M; Richards F
    Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
    Diawara L; Traoré MO; Badji A; Bissan Y; Doumbia K; Goita SF; Konaté L; Mounkoro K; Sarr MD; Seck AF; Toé L; Tourée S; Remme JH
    PLoS Negl Trop Dis; 2009 Jul; 3(7):e497. PubMed ID: 19621091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Onchocerciasis Elimination Program for the Americas (OEPA).
    Sauerbrey M
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():25-9. PubMed ID: 18718151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal.
    Traore MO; Sarr MD; Badji A; Bissan Y; Diawara L; Doumbia K; Goita SF; Konate L; Mounkoro K; Seck AF; Toe L; Toure S; Remme JH
    PLoS Negl Trop Dis; 2012; 6(9):e1825. PubMed ID: 23029586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can ivermectin mass treatments eliminate onchocerciasis in Africa?
    Winnen M; Plaisier AP; Alley ES; Nagelkerke NJ; van Oortmarssen G; Boatin BA; Habbema JD
    Bull World Health Organ; 2002; 80(5):384-91. PubMed ID: 12077614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mectizan and onchocerciasis: 10 years of Mectizan in Africa, a partnership for prolonged success].
    Pacqué M
    Sante; 1998; 8(1):77-8. PubMed ID: 9592889
    [No Abstract]   [Full Text] [Related]  

  • 7. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
    Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
    Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of onchocerciasis.
    Boatin BA; Richards FO
    Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid suppression of Onchocerca volvulus transmission in two communities of the Southern Chiapas focus, Mexico, achieved by quarterly treatments with Mectizan.
    Rodríguez-Pérez MA; Lutzow-Steiner MA; Segura-Cabrera A; Lizarazo-Ortega C; Domínguez-Vázquez A; Sauerbrey M; Richards F; Unnasch TR; Hassan HK; Hernández-Hernández R
    Am J Trop Med Hyg; 2008 Aug; 79(2):239-44. PubMed ID: 18689630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and control of onchocerciasis: the threshold biting rate of savannah onchocerciasis in Africa.
    Duerr HP; Eichner M
    Int J Parasitol; 2010 May; 40(6):641-50. PubMed ID: 19941867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year.
    Cupp EW; Cupp MS
    Am J Trop Med Hyg; 2005 Dec; 73(6):1159-61. PubMed ID: 16354830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.
    Tekle AH; Zouré HG; Noma M; Boussinesq M; Coffeng LE; Stolk WA; Remme JH
    Infect Dis Poverty; 2016 Jun; 5(1):66. PubMed ID: 27349645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
    Opara KN; Fagbemi BO
    J Vector Borne Dis; 2008 Mar; 45(1):29-37. PubMed ID: 18399314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular approaches to the control of onchocerciasis in Mexico].
    Rodríguez-Pérez MA
    Rev Latinoam Microbiol; 2005; 47(3-4):112-29. PubMed ID: 17061536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment and monitoring of onchocerciasis in Latin America.
    Rodríguez-Pérez MA; Unnasch TR; Real-Najarro O
    Adv Parasitol; 2011; 77():175-226. PubMed ID: 22137585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world.
    Nicholls RS; Duque S; Olaya LA; López MC; Sánchez SB; Morales AL; Palma GI
    Parasit Vectors; 2018 Apr; 11(1):237. PubMed ID: 29642939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes.
    Dadzie Y; Amazigo UV; Boatin BA; Sékétéli A
    Infect Dis Poverty; 2018 Jul; 7(1):63. PubMed ID: 29966535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards the elimination of onchocerciasis.
    Thylefors B; Alleman M
    Ann Trop Med Parasitol; 2006 Dec; 100(8):733-46. PubMed ID: 17227651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Guatemala.
    Wkly Epidemiol Rec; 2016 Oct; 91(43):501-5. PubMed ID: 27801556
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors Associated with Ivermectin Non-Compliance and Its Potential Role in Sustaining Onchocerca volvulus Transmission in the West Region of Cameroon.
    Senyonjo L; Oye J; Bakajika D; Biholong B; Tekle A; Boakye D; Schmidt E; Elhassan E
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004905. PubMed ID: 27529622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.